BeOne Medicines
ONC
#780
Rank
โ‚น3.007 T
Marketcap
โ‚น28,987
Share price
-3.77%
Change (1 day)
50.88%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Revenue for BeOne Medicines (ONC)

Revenue in 2026 (TTM): โ‚น514.18 Billion

According to BeOne Medicines's latest financial reports the company's current revenue (TTM ) is โ‚น546.12 Billion. In 2025 the company made a revenue of โ‚น479.64 Billion an increase over the revenue in the year 2024 that were of โ‚น326.86 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for BeOne Medicines from 2015 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น514.18 B7.2%
2025 โ‚น479.64 B46.74%
2024 โ‚น326.86 B59.69%
2023 โ‚น204.69 B74.7%
2022 โ‚น117.16 B33.83%
2021 โ‚น87.55 B287.58%
2020 โ‚น22.58 B-26.02%
2019 โ‚น30.53 B120.32%
2018 โ‚น13.86 B-8.94%
2017 โ‚น15.22 B20833.65%
2016 โ‚น72.71 M-87.59%
2015 โ‚น0.58 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
OPKO Health
OPK
โ‚น61.09 B-88.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
โ‚น21.5 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA